Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients
NCT ID: NCT03188588
Last Updated: 2020-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2017-01-31
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival
NCT00871962
Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPD
NCT02055885
Oxygen Therapy Remote Monitoring in COPD Patients.
NCT05473780
LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure
NCT00668408
Automated Oxygen Titration at Home in Patients With COPD on Home Oxygen
NCT05556187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First prescribed long term oxygenotherapy
Exclusion Criteria
* vital pronostic \< 3 months
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU Arnaud de Villeneuve MONTPELLIER
UNKNOWN
SOS Oxygene Mediterranee
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Bourdin, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU Montpellier, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Arnaud de Villeneuve
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A01244-47
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.